recombinant erythropoietin biosimilar (LG Life Sciences)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerecombinant erythropoietin biosimilar (LG Life Sciences)
Drug Alias Nameerythropoietinerythropoietin biosimilar (LG Life sciences)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical Ltd
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A